PMID- 19474193 OWN - NLM STAT- MEDLINE DCOM- 20090827 LR - 20220316 IS - 1522-1466 (Electronic) IS - 1931-857X (Print) IS - 1522-1466 (Linking) VI - 297 IP - 2 DP - 2009 Aug TI - Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. PG - F410-9 LID - 10.1152/ajprenal.00145.2009 [doi] AB - Elevated level of homocysteine (Hcy), known as hyperhomocysteinemia (HHcy), is associated with end-stage renal diseases. Hcy metabolizes in the body to produce hydrogen sulfide (H(2)S), and studies have demonstrated a protective role of H(2)S in end-stage organ failure. However, the role of H(2)S in HHcy-associated renal diseases is unclear. The present study was aimed to determine the role of H(2)S in HHcy-associated renal damage. Cystathionine-beta-synthase heterozygous (CBS+/-) and wild-type (WT, C57BL/6J) mice with two kidney (2-K) were used in this study and supplemented with or without NaHS (30 micromol/l, H(2)S donor) in the drinking water. To expedite the HHcy-associated glomerular damage, uninephrectomized (1-K) CBS(+/-) and 1-K WT mice were also used with or without NaHS supplementation. Plasma Hcy levels were elevated in CBS(+/-) 2-K and 1-K and WT 1-K mice along with increased proteinuria, whereas, plasma levels of H(2)S were attenuated in these groups compared with WT 2-K mice. Interestingly, H(2)S supplementation increased plasma H(2)S level and normalized the urinary protein secretion in the similar groups of animals as above. Increased activity of matrix metalloproteinase (MMP)-2 and -9 and apoptotic cells were observed in the renal cortical tissues of CBS(+/-) 2-K and 1-K and WT 1-K mice; however, H(2)S prevented apoptotic cell death and normalized increased MMP activities. Increased expression of desmin and downregulation of nephrin in the cortical tissue of CBS(+/-) 2-K and 1-K and WT 1-K mice were ameliorated with H(2)S supplementation. Additionally, in the kidney tissues of CBS(+/-) 2-K and 1-K and WT 1-K mice, increased superoxide (O(2)(*-)) production and reduced glutathione (GSH)-to-oxidized glutathione (GSSG) ratio were normalized with exogenous H(2)S supplementation. These results demonstrate that HHcy-associated renal damage is related to decreased endogenous H(2)S generation in the body. Additionally, here we demonstrate with evidence that H(2)S supplementation prevents HHcy-associated renal damage, in part, through its antioxidant properties. FAU - Sen, Utpal AU - Sen U AD - Dept. of Physiology & Biophysics, Univ. of Louisville School of Medicine, 500 S. Preston St., Louisville, KY 40202, USA. u0sen001@louisville.edu FAU - Basu, Poulami AU - Basu P FAU - Abe, Oluwasegun A AU - Abe OA FAU - Givvimani, Srikanth AU - Givvimani S FAU - Tyagi, Neetu AU - Tyagi N FAU - Metreveli, Naira AU - Metreveli N FAU - Shah, Karan S AU - Shah KS FAU - Passmore, John C AU - Passmore JC FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - R01 HL074185/HL/NHLBI NIH HHS/United States GR - R01 HL071010/HL/NHLBI NIH HHS/United States GR - R01 NS051568/NS/NINDS NIH HHS/United States GR - R01 HL088012/HL/NHLBI NIH HHS/United States GR - NS-51568/NS/NINDS NIH HHS/United States GR - HL-74185/HL/NHLBI NIH HHS/United States GR - HL-88012/HL/NHLBI NIH HHS/United States GR - HL-71010/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20090527 PL - United States TA - Am J Physiol Renal Physiol JT - American journal of physiology. Renal physiology JID - 100901990 RN - 0 (Antioxidants) RN - 0 (Desmin) RN - 0 (Membrane Proteins) RN - 0 (Sulfides) RN - 0 (nephrin) RN - 0LVT1QZ0BA (Homocysteine) RN - 11062-77-4 (Superoxides) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.24 (Mmp2 protein, mouse) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - EC 3.4.24.35 (Mmp9 protein, mouse) RN - EC 4.2.1.22 (Cystathionine beta-Synthase) RN - FWU2KQ177W (sodium bisulfide) RN - GAN16C9B8O (Glutathione) RN - ULW86O013H (Glutathione Disulfide) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Animals MH - Antioxidants/metabolism/*pharmacology MH - Apoptosis/drug effects MH - Cystathionine beta-Synthase/genetics/metabolism MH - Desmin/metabolism MH - Disease Models, Animal MH - Glutathione/metabolism MH - Glutathione Disulfide/metabolism MH - Homocysteine/blood MH - Hydrogen Sulfide/blood/*metabolism MH - Hyperhomocysteinemia/*drug therapy/genetics/metabolism MH - Kidney/*drug effects/metabolism/pathology MH - Kidney Failure, Chronic/genetics/metabolism/*prevention & control MH - Male MH - Matrix Metalloproteinase 2/metabolism MH - Matrix Metalloproteinase 9/metabolism MH - Membrane Proteins/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Nephrectomy MH - Oxidative Stress/drug effects MH - Proteinuria/metabolism/prevention & control MH - Sulfides/metabolism/*pharmacology MH - Superoxides/metabolism PMC - PMC2724247 EDAT- 2009/05/29 09:00 MHDA- 2009/08/28 09:00 PMCR- 2010/08/01 CRDT- 2009/05/29 09:00 PHST- 2009/05/29 09:00 [entrez] PHST- 2009/05/29 09:00 [pubmed] PHST- 2009/08/28 09:00 [medline] PHST- 2010/08/01 00:00 [pmc-release] AID - 00145.2009 [pii] AID - F-00145-2009 [pii] AID - 10.1152/ajprenal.00145.2009 [doi] PST - ppublish SO - Am J Physiol Renal Physiol. 2009 Aug;297(2):F410-9. doi: 10.1152/ajprenal.00145.2009. Epub 2009 May 27.